[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Tatjana |
| 2. | Perekonnanimi | Tallo |
| 3. | Töökoht | Tervise Arengu Instituut (TAI), viroloogia osakond |
| 4. | Ametikoht | Teadur |
| 5. | Sünniaeg | 25.01.1966 (päev.kuu.aasta) |
| 6. | Haridus | M.V. Lomonossovi nim. Moskva Riiklik Ülikool, keemik, 1982-1987 |
| 7. | Teenistuskäik | 1987-1993, NSVL MA Eksperimentaalse Patoloogia ja Teraapia Instituut,kõrgema haridusega laborant, Suhhumi, Gruusia 06.1994-09.1994, Profülaktilise Meditsiini Instituut, viroloogia osakond, kõrgema haridusega laborant. 10.1994-10.1995, Profülaktilise Meditsiini Instituut, viroloogia osakond, nooremteadur 11.1995-08.1997, Profülaktilise Meditsiini Instituut, viroloogia osakond, teadur, 09.1997-30.04.2003, Eksperimentaalse ja Kliinilise MeditsiiniInstituudi viroloogia osakonna teadur, 01.05.2003 - k.a. Tervise Arengu Instituut, viroloogia osakonna teadur |
| 8. | Teaduskraad | Magister |
| 9. | Teaduskraadi välja andnud asutus, aasta |
M.V. Lomonossovi nim. Moskva Riiklik Ülikool, 1994 |
| 10. | Tunnustused | 1991, Leiutuste ja avastuste riiklik komitee, Autorite Tunnustus No 1712411. Mus musculus hiirte kultiveeritavate hübriidrakkude tüvi - paavianide G-immuunoglobuliinide vastaste monoklonaalsete antikehade produtsent. 2002, 5th Nordic-Baltic Congress on Infectious Diseases Teadusliku Komitee esimene auhind: Sequential changes in HAV genotype distribution in Estonia 1994 to 2001 (St. Peterburg, Venemaa) 2004 - 6th Nordic-Baltic Congress on Infectious Diseases Teadusliku Komitee diplom: Molecular epidemiology of hepatitis C in Estonia, Palanga, Leedu . |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
Täitja kahes ETF grandis (1996-1998, reg. nr. 1993 ja 2002-2003, reg.nr. 4218).Täitja sihtfinantseeritavas teadusteemas "Loodusliku levikuga viirused ja viirusnakkused Eestis: looduslikud ohualad, tekitajate molekulaarbioloogiline iseloomustus, levik, organismi immuunvastus" (1999-2003). Eesti Immunoloogide Seltsi liige, alates 1995.a-st Euroopa Kliinilise Viroloogia Seltsi liige, alates 1995.a-st 1998.a-st –Eesti-poolne vastutav täitja Rootsi valitsuse rahastavas Balti mere piirkonna ühisprogrammis: Molecular epidemiology of viral hepatitis A, B ja C. 2004.a. jaanuarist Rootsi Karolinska Instituudi Mikrobioloogia ja Onkobioloogia Keskuse doktorant. |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Alates 1994.a-st - B- ja C-viirushepatiitide immunoepidemioloogilised omadused riskirühmades. Alates 1998.a-st Eestis levivate A-, B- ja C-hepatiidiviiruste molekulaarepidemioloogia ja geneetiline iseloomustus |
| 14. | Jooksvad grandid | ETF grant 5961 "Molekulaar-epidemioloogiline uuring Eestis isoleeritud B-hepatiidiviiruse genotüüpide leviku ja kliinilise tähtsuse väljaselgitamiseks" |
| 15. | Teaduspublikatsioonid |
Priimägi L, Tefanova V, Tallo T. Emerging viral hepatitis B and C in Estonia. Emerging Biological Threat. NATO Science Series. Series 1. Life and Behavioural Sciences, Ed. by G Berencsi, AS Khan, J Haloužka. IOS Press Amsterdam, Berlin, Oxford, Tokyo, Washington, DC. Published in cooperation with NATO Public Diplomacy Division, 2005, v. 370, 20-25. Priimägi L, Tefanova, V, Tallo T, Schmidt E. The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and C virus infection. Acta Medica Lituanica, 2005, 12, 3:28-31 Tallo T, Norder H, Tefanova V, Krispin T, Priimägi L, Mukomolov S, Mikhailov S, Magnius LO. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol, 2004 Oct; 74(2):221-7. Tefanova V, Tallo T, Jaroslavtsev N, Kikosh G, Krupskaja L, Lisitsina S, Kutsar K, Priimägi L. B- ja C-viirushepatiidid - aktuaalne epidemioloogiline probleem Eestis viimasel aastakümnel. Eesti Arst, 2004, 83(8):559-562. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T. Th1 and Th2 cytokines in chronic viral hepatitis B and C infection. Voprosy Virusologii, 2003, 48(4):37-40. Tallo T, Norder H, Tefanova V, Ott K, Prükk T, Solomonova O, Schmidt J, Zilmer L, Priimägi L, Krispin T, Magnius L. Sequental changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 2003, 70(2):187-193. Tefanova V, Priimägi L, Tallo T, Jaroslavtsev N. Hepatitis B and C infection among intravenous drug users in prisons and visitors of anonymous consulting rooms in Estonia: prevalence and risk factors. Connections, 2003 Nov; 14:8-9. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T, Kikoš G, Krupskaja L, Lisitsyna S. Th1-cytokines in chronic hepatitis B and C. Voprosy Virusologii, 2002, 47(3):23-27. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L, Lisitsyna S, Noorlind J. Hepatitis A in Estonia (1990-1999). Zh Mikrobiol Epidemiol Immunobiol 2002, (2):22-26. Tefanova V, Priimägi L, Tallo T. Functional and metabolic activity of peripheral blood neutrophiles in acute viral hepatitis B and C. Zh Mikrobiol Epidemiol Immunobiol 2001, 1:43-47. Tallo T, Lappalainen M, Tefanova V, Priimägi L. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in Northern Estonia. Acta virologica 2000, 44(3-4):175-178. Priimägi L, Kremerman I, Tallo T, Tefanova V, Luman M, Osadšaja G. The interferon system in patients maintained by hemodialysis, infected with hepatitis B and C. Voprosy Virusologii, 1999, 44(4):167-169. Priimägi L, Tefanova V, Tallo T, Osadšaja G. The function of the interferon system in inapparent and clinical hepatitis B and C infection. Voprosy Virusologii, 1999, 44, 2:85-88. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L. Epidemiological aspects of viral hepatitis in Estonia. Zh Mikrobiol Epidemiol Immunobiol 1999, 2:39-42. |
viimati muudetud: 03.08.2006
| Curriculum Vitae (CV) | ||
| 1. | First Name | Tatjana |
| 2. | Surname | Tallo |
| 3. | Institution | National Institute for Health Development |
| 4. | Position | Researcher |
| 5. | Date of birth | 25.01.1966 (day.month.year) |
| 6. | Education | 1982-1987, Basic University degree in Chemistry, Moscow State University named by M.V. Lomonosov, Moscow, Russia, Chemist |
| 7. | Research and professional experience |
1987-1993, Technician, Institute of Experimental Pathology and Therapy, Acad.Med. Sci., Immunotechnology Department, Georgia, Sukhumi 06.1994-09.1994, Technician,Institute of Preventive Medicine, group of immunodiagnistic of viral hepatitis, Tallinn, Estonia 10.1994-10.1995, Junior researcher, Institute of Preventive Medicine, group of immunodiagnistic of viral hepatitis, Tallinn, Estonia 11.1995-08.1997, researcher, Institute of Preventive Medicine, group of immunodiagnistic of viral hepatitis, Tallinn, Estonia, 09.1997 - 30.04.2003, Researcher,Estonian Institute of Experimental and Clinical Medicine, Tallinn, Estonia 01.05.2003 - till now, researcher, National Institute for Health Development, Virology Department, Tallinn, Estonia |
| 8. | Academic degree | Master of Science in Chemistry |
| 9. | Dates and sites of earning the degrees |
Moscow State University named by M.V.Lomonosov, Moscow, Russia, 1994 |
| 10. | Honours/awards | 1991, The State Committee on Inventions and Discoveries at the State Committee of the USSR on Science and Techniques. Author’s Certificate No. 1712411. A strain of hybridized cultivated cells of animals Mus musculus L – a producer of monoclonal antibodies to an immunoglobulin G of the baboons 2002, 5th Nordic-Baltic Congress of Infectious Diseases,Scientific Committee, award for the best presentation: Sequential changes in HAV genotype distribution in Estonia 1994 to 2001 (St. Petersburg, Russia) 2004 6th Nordic-Baltic Congress of Infectious Diseases, Scientific Committee, diploma: Molecular epidemiology of hepatitis C in Estonia, Palanga, Lithuania. |
| 11. | Research-administrative experience |
Co-applicant for two grants from Estonian Scientific Foundation (1996-1998, reg. nr. 1993 and 2002-2003, reg.nr. 4218) Co-applicant in project "Viral zoonoses and zoonotic viruses in Estonia: endemic areas, molecular-biological characteristics, distribution and immune reponse", 1999-2003, from Estonian Ministry of Education and Science From 1995, The member of Estonian Society for Immunology From 1995, The member of European Society for Clinical Virology From 1998, Estonian counterpart in program for Baltic countries: Molecular epidemiology of Viral Hepatitis A, B and C PhD student at Microbiology and Tumor Biology Center, Karolonska Institute, Stockholm, Sweden, from January, 2004. |
| 12. | Supervised dissertations | |
| 13. | Current research program | The study on immunoepidemiology of hepatitis B and C viruses in groups of incresed risk in Estonia (from 1994). The study on genetic characteristics and molecular epidemiology of hepatitis A, B and C viruses (from 1998). |
| 14. | Current grant funding | ESF grant 5961, 2004-2007, "Genotypes of HBV strains isolated in Estonia, their prevalence and clinical relevance: molecular epidemiological study" |
| 15. | List of most important publications |
Priimägi L, Tefanova V, Tallo T. Emerging viral hepatitis B and C in Estonia. Emerging Biological Threat. NATO Science Series. Series 1. Life and Behavioural Sciences, Ed. by G Berencsi, AS Khan, J Haloužka. IOS Press Amsterdam, Berlin, Oxford, Tokyo, Washington, DC. Published in cooperation with NATO Public Diplomacy Division, 2005, v. 370, 20-25. Priimägi L, Tefanova, V, Tallo T, Schmidt E. The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and C virus infection. Acta Medica Lituanica, 2005, 12, 3:28-31 Tallo T, Norder H, Tefanova V, Krispin T, Priimägi L, Mukomolov S, Mikhailov S, Magnius LO. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol, 2004 Oct; 74(2):221-7. Tefanova V, Tallo T, Jaroslavtsev N, Kikosh G, Krupskaja L, Lisitsina S, Kutsar K, Priimägi L. B- ja C-viirushepatiidid - aktuaalne epidemioloogiline probleem Eestis viimasel aastakümnel. Eesti Arst, 2004, 83(8):559-562. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T. Th1 and Th2 cytokines in chronic viral hepatitis B and C infection. Voprosy Virusologii, 2003, 48(4):37-40. Tallo T, Norder H, Tefanova V, Ott K, Prükk T, Solomonova O, Schmidt J, Zilmer L, Priimägi L, Krispin T, Magnius L. Sequental changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 2003, 70(2):187-193. Tefanova V, Priimägi L, Tallo T, Jaroslavtsev N. Hepatitis B and C infection among intravenous drug users in prisons and visitors of anonymous consulting rooms in Estonia: prevalence and risk factors. Connections, 2003 Nov; 14:8-9. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T, Kikoš G, Krupskaja L, Lisitsyna S. Th1-cytokines in chronic hepatitis B and C. Voprosy Virusologii, 2002, 47(3):23-27. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L, Lisitsyna S, Noorlind J. Hepatitis A in Estonia (1990-1999). Zh Mikrobiol Epidemiol Immunobiol 2002, (2):22-26. Tefanova V, Priimägi L, Tallo T. Functional and metabolic activity of peripheral blood neutrophiles in acute viral hepatitis B and C. Zh Mikrobiol Epidemiol Immunobiol 2001, 1:43-47. Tallo T, Lappalainen M, Tefanova V, Priimägi L. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in Northern Estonia. Acta virologica 2000, 44(3-4):175-178. Priimägi L, Kremerman I, Tallo T, Tefanova V, Luman M, Osadšaja G. The interferon system in patients maintained by hemodialysis, infected with hepatitis B and C. Voprosy Virusologii, 1999, 44(4):167-169. Priimägi L, Tefanova V, Tallo T, Osadšaja G. The function of the interferon system in inapparent and clinical hepatitis B and C infection. Voprosy Virusologii, 1999, 44, 2:85-88. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L. Epidemiological aspects of viral hepatitis in Estonia. Zh Mikrobiol Epidemiol Immunobiol 1999, 2:39-42. |
last updated: 03.08.2006
[ sulge aken ]